• Support from The Michael J. Fox Foundation for Parkinson’s Research to advance critical research into Parkinson’s disease biology • Nautilus’...
Teva delivers 3 consecutive years of growth - 2025 revenues of $17.3 billion, an increase of 4% year-over-year (YoY) in...
Ad hoc announcement pursuant to Art. 53 LR Regulatory dossier to obtain marketing authorization for QUVIVIQ has been submitted to...
Arbor Scientia Group has been assisting clients with a new online educational excellence course model designed to improve engagement, retention, and...
NEWARK, Del., Jan. 22, 2026 /PRNewswire/ -- The global optical coherence tomography (OCT) market is forecast to expand at a...
Recognition based on innovation, growth, strategic initiatives and robust partnerships indelivering regulatory-grade RWESAN FRANCISCO, Jan. 22, 2026 /PRNewswire/ -- Verana Health®,...
Success achieved in reducing trial costs and timelines drives 2026 platform enhancements designed to democratize clinical research analytics.CAMBRIDGE, Mass., Jan....
Dr. Miller’s appointment further enhances NKGen’s scientific and clinical advisory capabilities as the Company advances its research in Alzheimer’s and...
Population-scale AI system uses Claude to analyze millions of medical records to identify patients who qualify for guideline-recommended care and...
DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical...
ModMed, Epic, NextGen Healthcare, Netsmart, athenahealth, and Specialty Category Innovators Lead Black Book's 2026 Ambulatory EHR Rankings NEW YORK CITY,...
BOSTON, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a fully integrated, leading central nervous system...
VSee's Rapidly Configurable AI Telehealth Platform Addresses Rural Hospital Access and Financial Sustainability SAN JOSE, CALIFORNIA / ACCESS Newswire /...
VSee's Rapidly Configurable AI Telehealth Platform Addresses Rural Hospital Access and Financial Sustainability SAN JOSE, CALIFORNIA / ACCESS Newswire /...
DENVER, CO / ACCESS Newswire / January 12, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical...
The FDA has granted an in-person Type C meeting during the first quarter of 2026 New independent analyses across large observational...
Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on...
Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on...
Houston, Texas--(Newsfile Corp. - January 12, 2026) - Cannabis Bioscience International Holdings, Inc. (OTCID: CBIH), a public company trading on...
DALLAS and BOSTON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- M33 Growth, a Boston-based venture and growth-stage investment firm, today announced...